Aspirin use and risk for lung cancer: a meta-analysis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Oncology

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdq779PMID 21385885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

  2010cited by this paper
• Association of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort Study

  2009cited by this paper
• Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti‐inflammatory drugs

  2008influential reference
• Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women

  2008influential reference
• Postmenopausal Hormone Therapy and Lung Cancer Risk in the Cancer Prevention Study II Nutrition Cohort

  2008cited by this paper
• Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency

  2007cited by this paper
• Reduced Risk of Human Lung Cancer by Selective Cyclooxygenase 2 (Cox-2) Blockade: Results of a Case Control Study

  2007cited by this paper
• Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies.

  2007cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and Lung Cancer Risk: A Population-Based Case Control Study

  2007cited by this paper
• Use of NSAIDs, smoking and lung cancer risk

  2007influential reference
• Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

  2007cited by this paper
• A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.

  2007cited by this paper
• Reproductive and hormonal factors and risk of lung cancer in women: A prospective cohort study

  2007cited by this paper
• Nonsteroidal anti‐inflammatory drugs and risk of lung cancer

  2007influential reference
• Aspirin and cancer risk: an updated quantitative review to 2005

  2006cited by this paper
• Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study

  2006influential reference
• Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis.

  2005cited by this paper
• Use of nonaspirin NSAIDs and risk of lung cancer

  2005cited by this paper
• Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

  2005cited by this paper
• Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis

  2004cited by this paper
• Aspirin use and mortality from cancer in a prospective cohort study.

  2004cited by this paper
• Nonsteroidal Anti-inflammatory Drugs and Aspirin for the Prevention of Colorectal Adenomas and Cancer: A Systematic Review

  2004cited by this paper
• A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

  2003cited by this paper
• Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

  2003cited by this paper
• Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs

  2003cited by this paper
• Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis.

  2003cited by this paper
• Aspirin use and lung cancer in men

  2003influential reference
• Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis

  2003cited by this paper
• Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.

  2003cited by this paper
• Expression of estrogen receptors α and β in human lung tissue and cell lines

  2002cited by this paper
• Regular aspirin use and lung cancer risk

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Aspirin and lung cancer in women

  2002cited by this paper
• Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers.

  2002cited by this paper
• Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.

  2002cited by this paper
• Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung Cancers

  2001cited by this paper
• Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

  2001cited by this paper
• Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers.

  2001cited by this paper
• Breast cancer and NSAID use: a meta-analysis

  2001cited by this paper
• Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

  2000cited by this paper
• Beyond willow bark: aspirin in the prevention of chronic disease.

  2000cited by this paper
• Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study

  1998cited by this paper
• Lung cancer deaths in the United States from 1979 to 1992: an analysis using multiple-cause mortality data.

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (part I).

  1998cited by this paper
• Discrepancies between meta-analyses and subsequent large randomized, controlled trials.

  1997cited by this paper
• Nonsteroidal anti-inflammatory drugs and cancer.

  1995cited by this paper
• Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study

  1994cited by this paper
• Aspirin use and risk of fatal cancer.

  1993cited by this paper
• Aspirin use and chronic diseases: a cohort study of the elderly.

  1989cited by this paper
• Randomised trial of prophylactic daily aspirin in British male doctors

  1988cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE

  1955cited by this paper

• Risk insights for clinical medication: a Mendelian randomization study of 23 drugs and lung cancer.

  2026cites this paper
• Aspirin Inhibits Brain Metastasis of Lung Cancer via Upregulation of Tight Junction Protein Expression in Microvascular Endothelial Cells.

  2023cites this paper
• Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer

  2023cites this paper
• Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics

  2022cites this paper
• Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials

  2021cites this paper
• Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses

  2020cites this paper
• Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis

  2020cites this paper
• The efficacy and safety of valproate medications for migraine in adults: a meta-analysis.

  2020cites this paper
• Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis

  2019cites this paper
• Repurposed Drugs Trials by Cancer Type: Lung Cancer

  2019cites this paper
• Classic Epidemiology of Lung Cancer

  2018cites this paper
• Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies

  2018cites this paper
• Effects of aspirin on small-cell lung cancer mortality and metastatic presentation.

  2017cites this paper
• Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk

  2017cites this paper
• Selective inhibition by aspirin and naproxen of mainstream cigarette smoke-induced genotoxicity and lung tumors in female mice

  2016cites this paper
• Meta-analysis of aspirin use and risk of lung cancer shows notable results

  2016influential citation
• Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice

  2015cites this paper
• Chemopreventive effects of aspirin at a glance.

  2015cites this paper
• European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer.

  2015cites this paper
• Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms

  2015cites this paper
• Modulation by aspirin and naproxen of nucleotide alterations and tumors in the lung of mice exposed to environmental cigarette smoke since birth.

  2015cites this paper
• Aspirin Use and Lung Cancer Risk: A Possible Relationship? Evidence from an Updated Meta-Analysis

  2015cites this paper
• Can Aspirin and Cancer Prevention be Ageless Companions?

  2015cites this paper
• Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis

  2014cites this paper
• Non‐steroidal anti‐inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative

  2014cites this paper
• Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner.

  2014cites this paper
• Gene of the month: Interleukin 6 (IL-6)

  2014cites this paper
• Aspirin for the Primary Prophylaxis of Colorectal Cancer

  2013cites this paper
• Lung cancer chemoprevention: current status and future prospects

  2013cites this paper
• Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies.

  2013cites this paper
• Aspirin, nonsteroidal anti‐inflammatory drugs, paracetamol and risk of endometrial cancer: A case–control study, systematic review and meta‐analysis

  2013cites this paper
• Acetylsalicylic acid (ASA) in prevention of cancer

  2013cites this paper
• Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer.

  2013cites this paper
• Anticoagulant and fibrinolytic drugs - possible agents in treatment of lung cancer?

  2012cites this paper
• Aspirin and cancer risk: a quantitative review to 2011.

  2012cites this paper
• Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study.

  2012cites this paper